Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-11

Clinical Trial Update: Levobupivacaine Versus Liposomal Bupivacaine (Exparel®) for Treatment of Pain and Disability in Lateral Epicondylitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing levobupivacaine to liposomal bupivacaine (Exparel) for pain and disability in lateral epicondylitis (tennis elbow) with unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)
  • levobupivacaine (levobupivacaine)

Snippet

Sponsor: Turku University Hospital | Conditions: Tennis Elbow, Lateral Epicondylitis | Phase 4 | Status: UNKNOWN